These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12502700)

  • 1. The human insulin analogue aspart is not the almighty solution for insulin allergy.
    Takata H; Kumon Y; Osaki F; Kumagai C; Arii K; Ikeda Y; Suehiro T; Hashimoto K
    Diabetes Care; 2003 Jan; 26(1):253-4. PubMed ID: 12502700
    [No Abstract]   [Full Text] [Related]  

  • 2. Human insulin analog insulin aspart does not cause insulin allergy.
    Yasuda H; Nagata M; Moriyama H; Fujihira K; Kotani R; Yamada K; Ueda H; Yokono K
    Diabetes Care; 2001 Nov; 24(11):2008-9. PubMed ID: 11679481
    [No Abstract]   [Full Text] [Related]  

  • 3. The human insulin analog aspart can induce insulin allergy.
    JiXiong X; Jianying L; Yulan C; Huixian C
    Diabetes Care; 2004 Aug; 27(8):2084-5. PubMed ID: 15277447
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful management of type IV hypersensitivity reactions to human insulin analogue with injecting mixtures of biphasic insulin aspart and dexamethasone.
    Wen WL; Tsai KB; Lin YH; Hwang SJ; Hsiao PJ; Shin SJ; Hung WW
    J Formos Med Assoc; 2019 Apr; 118(4):843-848. PubMed ID: 30704815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glargine.
    Wu P; Ji C; Wang M; Zou S; Ge W
    Ann Endocrinol (Paris); 2013 Feb; 74(1):56-8. PubMed ID: 23351561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The insulin analog aspart: a safe alternative in insulin allergy.
    Airaghi L; Lorini M; Tedeschi A
    Diabetes Care; 2001 Nov; 24(11):2000. PubMed ID: 11679473
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin allergy.
    Raubenheimer PJ; Levitt NS
    S Afr Med J; 2004 Jun; 94(6):428-9. PubMed ID: 15250451
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion.
    Fujikawa T; Imbe H; Date M; Go Y; Kitaoka H
    Diabetes Res Clin Pract; 2012 Aug; 97(2):e31-3. PubMed ID: 22609054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous allergy to insulin: could statins and ACE inhibitors play a role? A case report.
    Pitrola D; MacIver C; Mallipedhi A; Udiawar M; Price DE; Stephens JW
    Diabetes Res Clin Pract; 2014 Apr; 104(1):e20-2. PubMed ID: 24534533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin allergies].
    Sola-Gazagnes A
    Soins; 2007 Apr; (714 Suppl):S2, S4-5. PubMed ID: 17569273
    [No Abstract]   [Full Text] [Related]  

  • 11. Allergy to human insulin.
    Fernández L; Duque S; Montalbán C; Bartolomé B
    Allergy; 2003 Dec; 58(12):1317. PubMed ID: 14616113
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs.
    Mollar-Puchades MA; Villanueva IL
    Diabetes Res Clin Pract; 2009 Jan; 83(1):e21-2. PubMed ID: 19070911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin aspart: a review.
    Owens D; Vora J
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):793-804. PubMed ID: 17014395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization for insulin allergy: a useful treatment also for local forms.
    Eguíluz-Gracia I; Rodríguez-Alvarez M; Cimarra-Alvarez M; Sanabria-Pérez MC; Martínez-Cócera C
    J Investig Allergol Clin Immunol; 2012; 22(3):215-6. PubMed ID: 22697012
    [No Abstract]   [Full Text] [Related]  

  • 15. Pan-insulin allergy and severe lipoatrophy complicating Type 2 diabetes.
    Tavare AN; Doolittle HJ; Baburaj R
    Diabet Med; 2011 Apr; 28(4):500-3. PubMed ID: 21392071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocytoclastic vasculitis associated with insulin aspart in a patient with type 2 diabetes.
    Marusic S; Vlahovic-Palcevski V; Ljubanovic D
    Int J Clin Pharmacol Ther; 2009 Oct; 47(10):603-5. PubMed ID: 19825323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin allergy; desensitization with crystalline zinc-insulin and steroid tapering.
    Yokoyama H; Fukumoto S; Koyama H; Emoto M; Kitagawa Y; Nishizawa Y
    Diabetes Res Clin Pract; 2003 Sep; 61(3):161-6. PubMed ID: 12965105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I allergy to insulin: case report and review of localized and systemic reactions to insulin.
    Hoffman AG; Schram SE; Ercan-Fang NG; Warshaw EM
    Dermatitis; 2008; 19(1):52-8. PubMed ID: 18346398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic allergic reaction by a human insulin analog.
    Barranco R; Herrero T; Tornero P; Barrio M; Frutos C; Rodríguez A; Malvetti V; Luisa Baeza M
    Allergy; 2003 Jun; 58(6):536-7. PubMed ID: 12757463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.